Continuing Education credits are not available for On Demand Webinars
Broadcast time: 1 hour 15 minutes

Series Overview: This 4-part webinar series is designed to introduce the recent revisions to the Pregnancy and Lactation Labeling Rule, discuss resulting policy decisions, and describe different approaches for proactively gathering relevant data. This series will follow the 2015 DIA Annual Meeting, and content will continue discussion of ideas generated at the 2015 Annual Meeting forum on methodologies to increase availability and understanding of the safety information for products used by pregnant and lactating women. The series will culminate in a workshop/forum at the DIA 2016 Annual Meeting on multiple and complementary approaches for collecting and sharing safety data on medications used by pregnant and lactating women.

The format for this webinar series is a panel discussion including industry and academic experts, government and regulatory authorities and other stakeholders, promoting a lively discussion and exchange of ideas.  A question-and-answer session will be offered for the live webinar audience. 

Part 4, the final webinar in this 4-part series, will describe ways that various federal agencies are synthesizing and disseminating research from postmarketing studies in pregnant and lactating women for use by prescribers and pharmacists. Compendium resources for searching available evidence on medication safety will be highlighted, along with innovative strategies for incorporating evidence into everyday clinical practice. Speakers will also discuss ongoing efforts to evaluate clinical—public health interventions to promote safer medication use in these patient groups.

Links to Remaining Series Parts

Series Part 1

Series Part 2

Series Part 3